MetLife, Inc.
MET · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $69,939,000 | $67,709,000 | $67,965,000 | $63,366,000 |
| % Growth | 3.3% | -0.4% | 7.3% | – |
| Cost of Goods Sold | $50,940,000 | $50,420,000 | $49,029,000 | $46,531,000 |
| Gross Profit | $18,999,000 | $17,289,000 | $18,936,000 | $16,835,000 |
| % Margin | 27.2% | 25.5% | 27.9% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,991,000 | $6,177,000 | $5,860,000 | $5,755,000 |
| SG&A Expenses | $5,991,000 | $6,177,000 | $5,860,000 | $5,755,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7,386,000 | $8,950,000 | $6,712,000 | $2,562,000 |
| Operating Expenses | $13,377,000 | $15,127,000 | $12,572,000 | $8,317,000 |
| Operating Income | $5,622,000 | $2,162,000 | $6,364,000 | $8,518,000 |
| % Margin | 8% | 3.2% | 9.4% | 13.4% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $5,622,000 | $2,162,000 | $6,364,000 | $8,518,000 |
| Tax Expense | $1,178,000 | $560,000 | $1,062,000 | $1,642,000 |
| Net Income | $4,426,000 | $1,578,000 | $5,284,000 | $6,855,000 |
| % Margin | 6.3% | 2.3% | 7.8% | 10.8% |
| EPS | 5.98 | 1.82 | 6.35 | 7.7 |
| % Growth | 228.6% | -71.3% | -17.5% | – |
| EPS Diluted | 5.94 | 1.81 | 6.3 | 7.65 |
| Weighted Avg Shares Out | 689,211 | 762,431 | 779,098 | 825,540 |
| Weighted Avg Shares Out Dil | 711,100 | 762,431 | 808,900 | 869,400 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,037,000 | $1,045,000 | $938,000 | $920,000 |
| Depreciation & Amortization | $714,000 | $718,000 | $673,000 | $694,000 |
| EBITDA | $7,373,000 | $3,925,000 | $7,975,000 | $10,132,000 |
| % Margin | 10.5% | 5.8% | 11.7% | 16% |